Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 公司是由华森有限整体变更设立的股份有限公司。2015年7月30日，各发起人股东签署《发起人协议》。根据发起人协议，各发起人以截至2015年5月31日经审计的华森有限账面净资产值320,571,845.36元，按照1:0.9358的比例折合成股份公司股本3亿元，每股面值1元，共计3亿股，其余20,571,845.36元作为股份公司的资本公积。 2015年7月30日，同致信德出具了《重庆华森制药有限公司股项目资产评估报告书》（同致信德评报字[2015]第146号）确认：截至2015年5月31日，华森有限经评估的净资产账面值为32,057.19万元，评估值为37,576.73万元，评估增值5,519.54万元，增值率为17.22%。2015年8月19日，大华会计师事务所对华森有限的整体变更情况出具了大华验字[2015]000816号《验资报告》，验证确认发起人的上述出资已全部足额到位。2015年8月25日，公司在重庆市工商行政管理局荣昌区分局完成工商变更登记，并领取了注册号为500226000003922的《营业执照》，注册资本为3亿元人民币。 公司是一家集中成药、化学研发生产和销售于体的国重点高新技 术企业。公司的产品涵盖消化系 统、精神经耳鼻喉科心脑血管术企业。公司的产品涵盖消化系 统、精神经耳鼻喉科心脑血管术企业。公司的产品涵盖消化系 统、精神经耳鼻喉科心脑血管术企业。公司的产品涵盖消化系统、精神经耳鼻喉科心脑血统、免疫系统等多个用药领域，包括威地美（铝碳酸镁片）、甘桔冰梅片、都梁软胶囊、长松（聚乙二醇4000散）、痛泻宁颗粒、八味芪龙颗粒、六味安神胶囊、融通（注射用阿魏酸钠）、注射用奥美拉唑钠、注射用甲磺酸加贝酯等。
Main Business 中成药、化学药的研发、生产和销售业务。
Legal Representative 游洪涛
Top Executives
董事长：游洪涛
董事：刘小英,游雪丹,游苑逸,梁燕,王瑛
独立董事：杜守颖,李嘉明,秦少容
Top 5 Shareholder
Shareholder name Nature Holding Date
成都地方建筑机械化工程有限公司流通A股45.04%31/03/2024
游洪涛限售股+流通A股17.34%31/03/2024
王瑛限售股+流通A股8.76%31/03/2024
刘小英限售股+流通A股8.60%31/03/2024
上海添橙投资管理有限公司－添橙添利一号私募证券投资基金流通A股1.41%31/03/2024
Company Secretary 游雪丹
Solicitors 北京懋德律师事务所
Auditors 大华会计师事务所（特殊普通合伙）
Tel No 023-67038855
Fax No 023-67622903
Website www.pharscin.com
Email ir@pharscin.com
Company Address
Register: 重庆市荣昌区工业园区
Office: 重庆市渝北区黄山大道中段89号
Listing Date 20/10/2017
Shares Capital
Shares Capital: 401,690,732
Total A Share: 401,690,732
Listed A Share: 284,291,978
Non-tradable A Share: 117,398,754
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.078
DPS(RMB)* ¥ 0.050
NBV Per Share(RMB)* ¥ 3.874
Market Capitalization(RMB) 4.294B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.